Large-scale testing (Phase 3)Active Not RecruitingNCT05653219
What this trial is testing
Efficacy and Safety of Ianalumab Versus Placebo in Addition to Eltrombopag in Primary Immune Thrombocytopenia Patients Who Failed Steroids
Who this might be right for
Primary Immune Thrombocytopenia
Novartis Pharmaceuticals 152